3 recruiting. 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Carcinoma, Skin Appendage: new trials by email Literature Review of Carcinoma, Skin Appendage trials Research Report on Carcinoma, Skin Appendage
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MIRRORS-FROZEN - Comparing Open Vs Robotic Surgery in the Management of Women with Complex Pelvic Adnexal Masses ≤ 8cm. MIRRORS-FROZEN Protocol., Standard open surgery - Ovarian Cancer, Ovarian Mass | Not applicable | Recruiting | Royal Surrey County Hospital NHS Foundation Trust | 40 | 2024-09-23 | 2024-10-15 |
| A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer MQ719, Pembrolizumab - Cutaneous Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma | Phase 1 | Recruiting | Memorial Sloan Kettering Cancer Center | 56 | 2023-05-04 | 2026-08-12 |
| Improved Diagnosis of Ovarian Cancer Ovarian Neoplasms, Ovarian Cancer | Recruiting | University of Aarhus | 1700 | 2021-05-15 | 2024-05-09 |
Ovarian Cysts (2) · Ovarian Neoplasms (2) · Adenocarcinoma, Sebaceous (1) · Carcinoma, Basal Cell (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Squamous Cell (1) · Fallopian Tube Neoplasms (1) · Hemangiosarcoma (1) · Melanoma (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Paget Disease, Extramammary (1) · Sarcoma, Kaposi (1) · Skin Neoplasms (1)
Adenocarcinoma (3) · Carcinoma (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Neoplasms, Adnexal and Skin Appendage (3) · Neoplasms, Glandular and Epithelial (3) · Adnexal Diseases (2) · Cysts (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2)
pembrolizumab (1)
Memorial Sloan Kettering Cancer Center (1) · Royal Surrey County Hospital NHS Foundation Trust (1) · University of Aarhus (1)
Denmark (1) · United Kingdom (1) · United States (1)
Ina Marie Dueholm Hjorth, MD (1) · Lara Dunn, MD (1) · Ole Mogensen, DMSci (1)